The purpose of this study is to assess the efficacy of supplementation with the Nicotinamide Adenine Dinucleotide (NAD+) precursor compound, Nicotinamide Riboside (NR), for improving physiological function (vascular, motor, and cognitive) in healthy middle-aged and older adults.
Overall, the proposed research project has the long-term potential to influence clinical practice by establishing novel therapies for treating multiple domains of age-associated physiological dysfunction and thereby reducing the risk of clinical disease and disability.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
30
Clinical Translational Research Center
Boulder, Colorado, United States
Incidence of treatment emergent adverse events
self reported side effects, vital signs, hematology, liver enzymes, markers of kidney function and blood chemistry
Time frame: 6 weeks
Endothelium Dependent Dilation
Brachial Artery Flow-Mediated Dilation (FMD)
Time frame: 6 weeks
Arterial Stiffness
Aortic Pulse Wave Velocity (PWV)
Time frame: 6 weeks
Cognitive Function
NIH Toolbox Cognitive Function Battery
Time frame: 6 weeks
Motor Function
NIH Toolbox Motor Function Battery
Time frame: 6 weeks
Systemic markers of oxidative stress and inflammation
Assessment of plasma C-reactive protein (CRP) and circulating and mononuclear cell-derived cytokine and antioxidant expression.
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.